GSK announced a $10.6 billion agreement to acquire Nuvalent, a clinical-stage biopharmaceutical company advancing precision-targeted oncology therapies, on June 9th, 2026. The acquisition will grant GSK the rights to zidesamtinib and neladalkib, two late-stage treatment candidates for non-small cell lung cancer (NSCLC) currently under regulatory review by FDA. According to a company press release announcing […]
Post Type Archives: News
BIO Unveils Dynamic Main Stage Lineup for 2026 Convention, Highlighting Innovation and Impact
The Biotechnology Innovation Organization (BIO) today announced its featured main stage speakers for the 2026 BIO International Convention, taking place June 22–25, 2026, in San Diego, California. This year’s main stage spotlights leaders at the intersection of science, technology, and purpose, highlighting the innovations and human stories driving the next era of biotechnology. Tuesday: Driven […]
Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies
Lonza and Stipple Bio, Inc., a private biotechnology company harnessing epitope-level precision to create targeted cancer therapies, today announced a multi-target licensing agreement to support the development of next-generation precision oncology ADC therapies. Stipple Bio is leveraging its Pointillist Platform to identify tumor-specific cell surface epitopes, which enable the development of potent, high therapeutic index […]
Lonza Advances Integrated DNA to IND Programs Through Acceleration, De Risking, and Innovation
Lonza, the world’s leading CDMO, announced today a strengthening of its biologics development services with an enhanced preclinical development offering designed to help customers make more confident early‑stage decisions while helping to accelerate timelines and reducing development risk. By combining early, decision‑enabling insights with accelerated execution, the enhanced approach addresses uncertainty at the point in […]
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
Novo Nordisk announced the launch of Wegovy® pill (semaglutide tablets) in the United Arab Emirates (UAE), the first country outside the United States to make the Wegovy® pill available to people living with obesity. The launch marks an important step in Novo Nordisk’s ambition to expand access to innovative obesity treatments and broaden treatment options […]
CPHI Americas relocates to Miami for 2027 to support global connectivity as part of the event’s evolution
Informa Markets, organizer of CPHI Americas, announced that the event will move to Miami in 2027. The relocation is designed to enhance international accessibility, increase executive participation and support the event’s continued growth as a leading platform for pharmaceutical innovation, outsourcing and strategic partnerships. The move reflects CPHI Americas’ commitment to creating a more connected, […]
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer. This reflects Ardena’s continued focus on scientific excellence across its integrated offering, supporting customers from early development through to later-stage clinical and commercial supply. Ariane will help ensure Ardena’s […]
Neuland reports record quarterly revenue of $83M* driven by commercial NCE projects
Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time Neuland Laboratories – a global contract development and manufacturing organization (CDMO) specialising in complex APIs – has reported its best ever quarterly revenue figures [circa $83m*]. The CDMO, which invested heavily in commercial-scale API and peptide manufacturing capacities, said […]
Recipharm boosts BFS capacity with strategic manufacturing investment
New BFS line adds significant sterile manufacturing capacity to support growing customer demand With 50 years of BFS expertise, Recipharm supports ophthalmic and vaccine programmes Integrated BFS capabilities span early feasibility, clinical supply and commercial manufacturing Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced a multi-million investment in a new Blow-Fill-Seal […]
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Quotient Sciences announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) – a landmark achievement highlighting the growing potential of AI to guide formulation design and accelerate drug development. The pioneering Phase I clinical study was initiated at Quotient Sciences’ UK facility following approval from the […]